Human acute poisoning incidents associated with neonicotinoid pesticides in the U.S. Incident Data System (IDS) database from 2018–2022 – frequency and severity show public health risks, regulatory failures
Open Access
- 20 November 2024
- journal article
- research article
- Published by Springer Nature in Environmental Health
- Vol. 23 (1) , 1-11
Abstract
Neonicotinoid pesticides (‘neonics’) – imidacloprid, thiamethoxam, clothianidin, acetamiprid, dinotefuran—are the most widely used class of insecticides in the world. They have a neurotoxic mechanism of action, similar to nicotine. They are detected in food, waterways, tap water, and breast milk. We make use of the non-occupational human pesticide poisoning reports in the U.S. Environmental Protection Agency (EPA) online Incident Data System (IDS). The data set contains individual incidents, and incidents aggregated and submitted in bulk to EPA. IDS reports are predominantly self-reported information of varying and often low level of detail and are not routinely validated or verified by EPA. We reviewed 842 non-occupational human poisoning incidents associated with neonics in the IDS from 2018 through 2022. There are four human fatality reports, two associated with clothianidin and two with acetamiprid. Major illnesses such as seizures were reported in several cases, including with dinotefuran cockroach bait product, and an imidacloprid lawn product. Moderate poisonings make up 88% of the total poisonings (740 of 842), with most of those associated with imidacloprid (547 incidents) or dinotefuran (102 incidents). Common reported symptoms classified as moderate often included two or more of the following: headaches; dizziness; lethargy; eye or throat irritation; skin itching and rash; chemical burns and skin peeling; face swelling; muscle weakness or tremors; vomiting; diarrhea; pain and tightness in chest; open sores; and general pain. These incidents stem mainly from residential uses, such as lawn and garden insect repellents, home pest treatments for bed bugs or roaches, and products used to treat pets for fleas and ticks. Given the evidence of neurotoxicity, EPA should use its legal authority to cancel unsafe products and unnecessary uses – including from seed treatments, and residential pet and lawncare products – to prevent further human suffering.Keywords
All Related Versions
This publication has 39 references indexed in Scilit:
- Country-specific effects of neonicotinoid pesticides on honey bees and wild beesScience, 2017
- Effects of Neonicotinoid Pesticide Exposure on Human Health: A Systematic ReviewEnvironmental Health Perspectives, 2017
- Relationship between Urinary N-Desmethyl-Acetamiprid and Typical Symptoms including Neurological Findings: A Prevalence Case-Control StudyPLOS ONE, 2015
- Residential agricultural pesticide exposures and risk of selected congenital heart defects among offspring in the San Joaquin Valley of CaliforniaEnvironmental Research, 2014
- Neurobehavioural effects of developmental toxicityThe Lancet Neurology, 2014
- Residential Agricultural Pesticide Exposures and Risk of Neural Tube Defects and Orofacial Clefts Among Offspring in the San Joaquin Valley of CaliforniaAmerican Journal of Epidemiology, 2014
- Autism spectrum disorder, flea and tick medication, and adjustments for exposure misclassification: the CHARGE (CHildhood Autism Risks from Genetics and Environment) case–control studyEnvironmental Health, 2014
- NEONICOTINOID INSECTICIDE TOXICOLOGY: Mechanisms of Selective ActionAnnual Review of Pharmacology and Toxicology, 2005
- Compliance with required pesticide‐specific protective equipment useAmerican Journal of Industrial Medicine, 2001
- Factors Associated with Safe Use of Agricultural Pesticides in MinnesotaThe Journal of Rural Health, 1996